Current prescribing patterns for hypertension and atherosclerotic cardiovascular disease (ASCVD) in MSF programmes and their association with treatment outcomes and renal function: could there be a role for fixed dose combination drugs?

Principal investigator

Helen Bygrave
Purpose of study
Purpose of study

The purpose of the study is to inform the revision of guidelines for hypertension and ASCVD care in MSF noncommmunicble (NCD) disease projects, to simplify treatment for both patient and prescriber, in order to improve overall medication use (pres...

Study status

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline

Publications

No publications recorded
Previous study
Next study